![]() RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | ![]() Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. | ||
Founding Date | Founding Date 2009 | Founding Date 2015 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Jupiter, US HQ | Locations South San Francisco, US HQ | Locations Waltham, US HQ |
Employees | Employees 5 | Employees 64 | Employees 69 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 69.8 m | Valuation ($) 43.5 m |
Financial | |||
Net income | Net income N/A | Net income ($129.9m) (FY, 2024) | Net income ($35m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 176m | Total funding raised $ 233m |

RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company
Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics.
View company